Alergologia Polska - Polish Journal of Allergology

Full text

2/2026 vol. 13
Letter to the Editor

Managing PEG-asparaginase hypersensitivity: successful desensitisation after life-threatening anaphylaxis

  1. Department of Paediatric Allergy and Immunology, Faculty of Medicine, İstanbul Medeniyet University, İstanbul, Turkey
  2. Department of Paediatric Haematology and Oncology, Faculty of Medicine, İstanbul Medeniyet University, İstanbul, Turkey

Alergologia Polska – Polish Journal of Allergology 2026; 13, 2: 176–180


Data publikacji online: 2026/04/24
Article file
Managing PEG.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Narta UK, Kanwar SS, Azmi W. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit Rev Oncol/Hematol 2007; 61: 208-21.
  2. Graham ML. Pegaspargase: a review of clinical studies. Adv Drug Deliv Rev 2003; 55: 1293-302.
  3. Sahiner UM, Tolga Yavuz S, Gökce M, et al. Anaphylactic reaction to polyethylene-glycol conjugated-asparaginase: premedication and desensitization may not be sufficient. Pediatr Int 2013; 55: 531-3.
  4. August KJ, Farooki S, Fulbright JM, et al. Desensitization to PEGaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma. Pediatr Blood Cancer 2020; 67: e28021.
  5. Concha S, Barriga F, Ovalle P, Hoyos-Bachiloglu R. A 12-steps desensitization protocol for pediatric patients with hypersensitivity to pegylated asparaginase. Ann Allergy Asthma Immunol 2020; 124: 208-10.
  6. Verma A, Chen K, Bender C, et al. PEGylated E. coli asparaginase desensitization: an effective and feasible option for pediatric patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegaspargase in the absence of asparaginase Erwinia chrysanthemi availability. Pediatr Hematol Oncol 2019; 36: 277-86.
  7. Cecconello DK, Rechenmacher C, De Souza Silva K A, et al. Follow our path with asparaginase activity: one technique, but different uses in clinical practice. Exp Hematol Oncol 2022; 11: 86.
  8. Cramer J, Graff J, Serebin D. Tolerability and efficacy of a 1-bag pegaspargase desensitization protocol in pediatric oncology patients. J Pediatr Hematol Oncol 2022; 44: 623-7.
  9. Swanson HD, Panetta JC, Barker PJ, et al. Predicting success of desensitization after pegaspargase allergy. Blood 2020; 135: 71-5.
  10. Zacharias J, Mulieri K, McGregor L, Fausnight T. P030 desensitization protocol for pegaspargase anaphylaxis. Ann Allergy Asthma Immunol 2016; 117 (5 Suppl): S31.
Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
without publication fees